[ Price : $8.95]
The CDER Office of Prescription Drug Promotion warns Alkermes about a misleading Vivitrol print ad that omits important risk infor...[ Price : $8.95]
FDA accepts for review a Novartis supplemental BLA for Xolair (omalizumab) for treating nasal polyps in adult patients who do not ...[ Price : $8.95]
The Senate votes 91-2 to approve legislation to reform the over-the-counter drug regulatory system.[ Price : $8.95]
FDAs Cardiovascular and Renal Drug Advisory Committee votes 11-2 against recommending approval of Correvio Pharmas vernakalant for...[ Price : $8.95]
FDA clears an ImpediMed 510(k) for Sozo, intended for use as an aid in assessing protein calorie malnutrition.[ Price : $8.95]
Attorney Michelle Yeary says a DC federal court decision might open the way for FDA Warning Letters to be considered final agency ...[ Price : $8.95]
The Council for Responsible Nutrition praises the Supreme Courts refusal to hear an Amrin appeal of a fish oil dietary supplement ...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Rempex Pharmaceuticals Vabo...